SCHEMBL10175245

SCHEMBL10175245

O=C(O)c1ccn2c(CO)c(-c3ccc(Cl)cc3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDH1 P12830 1/20 0.48
APC P25054 1/20 0.48
CTNNB1 P35222 1/20 0.48
TCF7L2 Q9NQB0 1/20 0.48
AKT1 P31749 1/20 0.44
AKT2 P31751 1/20 0.44
GABRB2 P47870 2/20 0.44
GABRA2 P47869 1/20 0.44
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SLC2A2 P11168 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRA5 P31644 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1691410 0.99 CDH1 (0.47) CDH1APCCTNNB1TCF7L2AKT1
SCHEMBL1691274 0.89 SLC2A1 (0.46) AKT1AKT2GABRB2GABRA2KCNK3
SCHEMBL1691856 0.86 AKT1 (0.47) AKT1AKT2GABRB2GABRA2KCNK3
SCHEMBL1691336 0.84 KDM4E (0.48) AKT1AKT2GABRB2GABRA2KCNK3
SCHEMBL10175208 0.81 GABRA2 (0.53) GABRB2GABRA2SLC2A2NR1I2ABCB11
SCHEMBL1691661 0.76 KDM4E (0.69) GABRB2KCNK3KCNK9POLBGABRA1
SCHEMBL1691246 0.75 AHR (0.44) AKT1AKT2KCNK3KCNK9POLB
SCHEMBL7233460 0.75 SMN1; SMN2 (0.52) POLBMAPTSLC2A2KDM4ENPC1
SCHEMBL7554629 0.75 KCNK3 (0.47) GABRB2GABRA2KCNK3KCNK9SLC2A2
Trifluoroacetic Acid SCHEMBL1691916 0.75 CASP3 (0.43) KCNK3KCNK9NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
US-20120010188-A1 Imidazopyridine Compounds PROMIMAGEN LTD. (GB) 2012-01-12 US disclosed
US-20120010188-A1 Imidazopyridine Compounds PROMIMAGEN LTD. (GB) 2012-01-12 US disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010188-A1 Imidazopyridine Compounds SSB, MIF, IDO1 CDH1 4838/4885APC 827/4885CTNNB1 4212/4885
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 CDH1 4838/4885APC 827/4885CTNNB1 4212/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT CDH1 4838/4885APC 496/4885CTNNB1 3596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.